Behind CURIS System: A Gaseous Biodecontamination Solutions Provider
July 7th 2022CURIS® provides portable and fixed decontamination systems. CURIS® has revolutionized the biodecontamination world with efficacious hybrid hydrogen peroxide decontamination, which delivers a mix of vapor and micro-aerosols to each space at precisely calibrated intervals. Recent challenges in staffing for Life Sciences inspired CURIS® to help labs save time and money by creating a single system that completes multiple decontamination tasks in virtually any space, including as an integrated system for on-demand biodecontamination.
Energy Markets Volatility: The Rocky Road to Net Zero
June 6th 2022According to the International Energy Agency, COVID-19 initially lead to a “staggering” decline in energy demand and depressed energy prices. Less than two years later, we are now faced with the cost of energy at an all-time high. Rapidly growing demand and, more recently, the Russian invasion of Ukraine, are driving energy prices to unprecedented highs and challenging security of supply. It is against this backdrop of uncertainty that we are simultaneously attempting to avert climate disaster through how we generate, store, use and manage energy. Should renewable or net zero carbon targets be postponed or is this all part of the rocky road to net zero?
Drug Digest: Emerging Therapies in All Shapes and Sizes
May 5th 2022In this episode of Drug Digest, Pharmaceutical Technology editors, Felicity Thomas and Feliza Mirasol, examine the topic of emerging therapies in more detail, covering subjects such as the challenges of scale, the potential benefits of drug delivery innovation, importance of early analytical studies, the evolution of the regulatory landscape, and differences between regional regulatory requirements.
The New Opportunity in Pharmaceutical Outsourcing: Portfolio Maintenance
March 9th 2022For decades, the power and potential of outsourcing has been viewed as a way for pharmaceutical companies to gain access to specialized domain expertise across geographic regions and achieve cost savings amidst a highly complex and diverse regulatory environment. In the face of dwindling drug pipelines, complex regulations and block-busters crossing their patent exclusivity, mature products offer a revenue stream for companies to sustain their bottom lines in a hyper-competitive global market.
Drug Digest: Pairing the Right APIs and Excipients for Optimizing Formulations
February 3rd 2022In this episode of Drug Digest, Chris Spivey, editorial director, and Meg Rivers, senior editor, dive into APIs, excipients, and formulation advances, specifically pairing the right APIs and excipients for optimizing formulations.
Tech Talks: Cell & Gene Therapy Series
February 2nd 2022Cell and gene therapies continue to expand rapidly, with an anticipated exponential growth over the next five years. This rapid growth has left an urgent need for industry scientists to gather and share lessons learned concerning bioanalytical, biomarker and regulatory strategies. This series provides insight from PPD Laboratories’ experts into a variety of cell and gene therapy (CGT) modalities in the bioanalytical community, with detailed discussions that leverage their experience with technologies and modalities within this CGT sphere.
Ultra-Sensitive LC-MRM Analysis for Trastuzumab emtansine Quantification in Rat Plasma
December 3rd 2021Eshani Nandita, Ph.D., Global Biopharma Quant Technical Marketing Lead at Sciex, presented the company’s poster Ultra-Sensitive LC-MRM Analysis for Trastuzumab emtansine Quantification in Rat Plasma at AAPS 2021 PharmSci 360.
Impact of Opacifier Type in a Film Coating Formulation on Photostability of Tablet Ingredients
November 15th 2021Manish Ghimire, Ph.D., Product Development Manager at Colorcon, Inc., presented the company’s poster Impact of Opacifier Type in a Film Coating Formulation on Photostability of Tablet Ingredients at AAPS 2021 PharmSci 360.